Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-02 4:16 pm Sale | 2022-02-23 | 13G | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 27,356,043 9.700% | -400 (-0.00%) | Filing History |
| 2022-03-02 3:38 pm Purchase | 2022-02-23 | 13D | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 27,356,443 9.700% | 797,000 (+3.00%) | Filing History |
| 2022-02-22 5:19 pm Unchanged | 2021-07-02 | 13D | Amicus Therapeutics, Inc. FOLD | Perceptive Advisors LLC | 26,559,443 9.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 9:12 pm Purchase | 2021-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Perceptive Advisors LLC | 4,849,912 9.800% | 672,191 (+16.09%) | Filing History |
| 2022-02-14 9:10 pm Unchanged | 2021-12-31 | 13G | Quotient Limited QTNT | Perceptive Advisors LLC | 405,020 15.800% | 0 (Unchanged) | Filing History |
| 2022-02-14 9:01 pm Purchase | 2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO | Perceptive Advisors LLC | 7,128,755 4.800% | 422,487 (+6.30%) | Filing History |
| 2022-02-14 9:01 pm Sale | 2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Perceptive Advisors LLC | 0 0.000% | -2,058,068 (Position Closed) | Filing History |
| 2022-02-14 8:59 pm Sale | 2021-12-31 | 13G | Zymeworks Inc. ZYME | Perceptive Advisors LLC | 3,679,845 6.600% | -621,154 (-14.44%) | Filing History |
| 2022-02-14 8:55 pm Unchanged | 2021-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 11,933,387 6.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 7:33 pm Sale | 2021-12-31 | 13G | VYNE Therapeutics Inc. VYNE | Perceptive Advisors LLC | 134,756 4.500% | -142,349 (-51.37%) | Filing History |
| 2022-02-14 7:09 pm Sale | 2021-12-31 | 13G | AnaptysBio, Inc. ANAB | Perceptive Advisors LLC | 0 0.000% | -1,495,336 (Position Closed) | Filing History |
| 2022-02-14 6:59 pm Sale | 2021-12-31 | 13G | Protara Therapeutics, Inc. TARA | Perceptive Advisors LLC | 421,641 3.800% | -186,903 (-30.71%) | Filing History |
| 2022-02-14 6:59 pm Sale | 2021-12-31 | 13G | Outset Medical, Inc. OM | Perceptive Advisors LLC | 124,226 4.000% | -65,628 (-34.57%) | Filing History |
| 2022-02-14 6:55 pm Unchanged | 2021-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 847,650 9.600% | 0 (Unchanged) | Filing History |
| 2022-02-14 6:33 pm Purchase | 2021-12-31 | 13G | Coherus Oncology, Inc. CHRS | Perceptive Advisors LLC | 5,407,798 7.000% | 735,962 (+15.75%) | Filing History |
| 2022-02-14 6:31 pm Unchanged | 2021-12-31 | 13G | BCLS Acquisition Corp. BLSA | Perceptive Advisors LLC | 1,000,000 6.700% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:46 pm Purchase | 2021-12-31 | 13G | POINT Biopharma Global Inc. PNT | Perceptive Advisors LLC | 1,193,995 1.300% | 1,193,995 (New Position) | Filing History |
| 2022-02-14 5:44 pm Purchase | 2021-12-31 | 13G | IVERIC bio, Inc. ISEE | Perceptive Advisors LLC | 6,480,000 5.700% | 1,997,287 (+44.56%) | Filing History |
| 2022-02-14 5:44 pm Sale | 2021-12-31 | 13G | Oncorus, Inc. ONCR | Perceptive Advisors LLC | 999,812 3.900% | -990,175 (-49.76%) | Filing History |
| 2022-02-14 5:33 pm Sale | 2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Perceptive Advisors LLC | 3,283,783 5.900% | -409,733 (-11.09%) | Filing History |